Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk Patients

Lonn EM, 1994, Circulation, 90, 2056, 10.1161/01.CIR.90.4.2056

10.1016/0140-6736(92)92889-N

10.1056/NEJM199209033271001

10.1056/NEJM199311113292004

10.1056/NEJM200001203420302

1996, Can J Cardiol, 12, 127

1993, Lancet, 342, 821

10.1016/S0033-0620(85)80003-7

1994, BMJ, 308, 81, 10.1136/bmj.308.6921.81

Law M. Lipids and cardiovascular disease. In: Yusuf S, Cairns JA, Camm AJ, Fallen EL, Gersh BJ, eds. Evidence based cardiology. London: BMJ Books, 1998:191-205.

10.1016/0140-6736(90)90944-Z

10.1016/S0140-6736(98)04311-6

Clarke R, 1999, Am J Epidemiol, 150, 341, 10.1093/oxfordjournals.aje.a010013

10.1056/NEJM199209033271003

10.1056/NEJM199512213332503

10.1001/jama.273.18.1450

10.1007/s001250050880

10.1097/00004872-199917040-00014

10.1016/S0140-6736(98)05012-0

10.1016/S0140-6736(98)04433-X

10.1016/S0140-6736(98)10363-X